2022 US IPO Bootcamp


How, what, where and when of a successful US IPO

Tuesday 8th November (Virtually)

In line with our mission to support funding, financing and deal making in the sector, LSX teaming up with the world’s foremost experts, advisers, bankers and consultants to help CEOs and CFOs navigate the how, what, where and when of a successful US IPO.

The Bootcamp will be held virtually as a pre-event workshop the week before the Investival Showcase

The IPO Bootcamp is an invitation only online workshop, and series of 1:1 consultations. It provides CEOs and CFOs of life science companies contemplating a US IPO a unique opportunity to come together for a series of frank and open discussions with peers, case studies from executives who have recently been through the process, and for tailored and 1-2-1 advice with the region’s foremost experts, advisers, bankers and consultants.

The IPO Bootcamp is by invitation only for qualifying companies. If you are interested in a seat at the bootcamp please message josh@lsxleaders.com

Co-hosted by:

citi Logo    FTI Consulting Logo    Goodwin Logo    RSM Logo    Spencer Stuart Logo    SVB Securities Logo

 

Agenda:

11:00    Presentation: The State Of The US IPO Market

Patrick Morley, Director, Equity Capital Markets SVB Leerink


11:20    Roundtable: Determining And Defining Your IPO Strategy

  • Is an IPO right for you?
  • Market timing
  • US vs Euro listings – pros and cons
  • Requirements for going public in the USA
  • What to expect when you are public company in the USA
  • IPO checklist

Gabe Cavazos, Managing Director Biotechnology, SVB Leerink
Patrick Morley, Director, Equity Capital Markets SVB Leerink
Rob Puopolo, Partner, Goodwin
Andrew Harrow, Partner, Goodwin
Niccolò Cominacini, VP Depositary Receipts, Citi
Sophie Russell, EMEA DR Sales, Citi
Asaf Homossany, Managing Director – EMEA, Nasdaq
Isabella Schidrich, Senior Managing Director, Nasdaq
Niren Thanky, Head of Healthcare EMEA, Spencer Stuart
JJ, Marshall, Consultant, Biopharma Practice, Spencer Stuart
Jim Polson, Managing Director, FTI Consulting
Ankur Vyas, Senior Director, RSM
Chris Martin, Principal, RSM


12:10    IPO Case Study:

Jorge Santos da Silva , CEO, MoonLake Immunotherapeutics


12:40    Break


13:30    1:1 Corporate/Expert Advisor Consultations


17:00    End of Bootcamp

 

DOWNLOAD BROCHURE